Adenosine-modulating synthetic high-density lipoprotein for chemoimmunotherapy of triple-negative breast cancer DOI

Xiang Gong,

Chao Zheng, Ying Cai

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 367, С. 637 - 648

Опубликована: Фев. 8, 2024

Язык: Английский

A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy DOI
Yuan Chen,

Zhuo Yao,

Peilian Liu

и другие.

Acta Biomaterialia, Год журнала: 2023, Номер 159, С. 275 - 288

Опубликована: Янв. 26, 2023

Язык: Английский

Процитировано

48

Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy DOI
Chong Wang, Qiang Wang, Huimin Wang

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 353, С. 391 - 410

Опубликована: Дек. 6, 2022

Язык: Английский

Процитировано

52

Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy DOI Creative Commons
Qiaolin Liu, Yuliang Zhao, Huige Zhou

и другие.

Regenerative Biomaterials, Год журнала: 2023, Номер 10

Опубликована: Янв. 1, 2023

Abstract Ferroptosis, a completely new form of regulated cell death, is mainly caused by an imbalance between oxidative damage and reductive protection has shown great anti-cancer potential. However, existing small-molecule ferroptosis inducers have various limitations, such as poor water solubility, drug resistance low targeting ability, hindering their clinical applications. Nanotechnology provides opportunities for ferroptosis-driven tumor therapy. Especially, stimuli-responsive nanomaterials stand out among others been widely researched because unique spatiotemporal control advantages. Therefore, it’s necessary to summarize the application those in ferroptosis. Here, we describe physiological feature illustrate current challenges induce cancer Then, that are classified elaborated according external internal stimuli. Finally, future perspectives field proposed. We hope this review facilitates paving way design intelligent nano-ferroptosis inducers.

Язык: Английский

Процитировано

42

Application of molecular dynamics simulation in self-assembled cancer nanomedicine DOI Creative Commons

Xueli Xu,

Ao Liu, Shuangqing Liu

и другие.

Biomaterials Research, Год журнала: 2023, Номер 27(1)

Опубликована: Фев. 9, 2023

Self-assembled nanomedicine holds great potential in cancer theragnostic. The structures and dynamics of can be affected by a variety non-covalent interactions, so it is essential to ensure the self-assembly process at atomic level. Molecular (MD) simulation key technology link microcosm macroscale. Along with rapid development computational power methods, scientists could simulate specific intermolecular interactions. Thus, some experimental observations explained microscopic level synthesis would have traces follow. This review not only outlines concept, basic principle, parameter setting MD simulation, but also highlights recent progress for self-assembled nanomedicine. In addition, physicochemical parameters structure interaction between various assembled molecules under are discussed. Therefore, this will help advanced novice researchers quickly zoom on fundamental information gather thought-provoking ideas advance subfield

Язык: Английский

Процитировано

32

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics DOI Creative Commons

Qing Pei,

Bowen Jiang,

Dengyuan Hao

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2023, Номер 13(8), С. 3252 - 3276

Опубликована: Март 5, 2023

Chemotherapy has occupied the critical position in cancer therapy, especially towards post-operative, advanced, recurrent, and metastatic tumors. Paclitaxel (PTX)-based formulations have been widely used clinical practice, while therapeutic effect is far from satisfied due to off-target toxicity drug resistance. The caseless multi-components make preparation technology complicated aggravate concerns with excipients-associated toxicity. self-assembled PTX nanoparticles possess a high content could incorporate various functional molecules for enhancing index. In this work, we summarize self-assembly strategy diverse nanodrugs of PTX. Then, advancement tumor emphasis on mono-chemotherapy, combinational theranostics, outlined. Finally, challenges potential improvements briefly spotlighted.

Язык: Английский

Процитировано

29

Structure–Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles DOI
Yinxian Yang, Xiuhong Li,

Jiaxuan Song

и другие.

Nano Letters, Год журнала: 2023, Номер 23(4), С. 1530 - 1538

Опубликована: Янв. 31, 2023

Albumin has emerged as a versatile drug carrier. To harness albumin carrier for doxorubicin (DOX), we synthesized three acid-labile DOX prodrugs using stearic acid (SA), oleic (OA), and linoleic (LA) the albumin-binding motif, respectively. Different from conventional nanodrugs (such Abraxane, with loading of 10%), assembled nanoparticles (NPs) have an ultrahigh (>35%). Noteworthy, demonstrated that saturation fatty acids exerted great influence on colloidal stability prodrug NPs, thus affecting their in vivo pharmacokinetics, tumor accumulation antitumor efficacy. Furthermore, hydrazone bond-bridged could remain intact bloodstream but allow to be released acidic environment, resulting improved efficacy safety. Our work gives novel insights into structure-to-efficacy relationship albumin-bound provides simple strategy advanced nanomedicines.

Язык: Английский

Процитировано

26

Disturbing cytoskeleton by engineered nanomaterials for enhanced cancer therapeutics DOI Creative Commons

Xueli Xu,

Shanbin Xu,

Jipeng Wan

и другие.

Bioactive Materials, Год журнала: 2023, Номер 29, С. 50 - 71

Опубликована: Июнь 29, 2023

Cytoskeleton plays a significant role in the shape change, migration, movement, adhesion, cytokinesis, and phagocytosis of tumor cells. In clinical practice, some anti-cancer drugs achieve cytoskeletal therapeutic effects by acting on different protein components. However, absence cell-specific targeting, unnecessary recombination organisms would be disastrous, which also bring about severe side during anticancer process. Nanomedicine have been proven to superior small molecule cancer treatment due better stability lower effects. Therefore, this review summarized recent developments various nanomaterials disturbing cytoskeleton for enhanced therapeutics, including carbon, noble metals, metal oxides, black phosphorus, calcium, silicon, polymers, peptides, metal-organic frameworks, etc. A comprehensive analysis characteristics therapy as well future prospects challenges towards application were discussed. We aim drive emerging topic through refreshing perspectives based our own work what we learnt from others. This will help researchers quickly understand relevant information further advance development nanomedicine.

Язык: Английский

Процитировано

26

Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review DOI Creative Commons
Xuan Meng,

Yongli Shen,

Huanyu Zhao

и другие.

Journal of Nanobiotechnology, Год журнала: 2024, Номер 22(1)

Опубликована: Сен. 28, 2024

Язык: Английский

Процитировано

17

Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies DOI Creative Commons
Shiyi Zuo, Tian Liu, Lingxiao Li

и другие.

Cell Reports Medicine, Год журнала: 2024, Номер 5(3), С. 101432 - 101432

Опубликована: Фев. 21, 2024

Dimeric prodrug nanoassemblies (DPNAs) stand out as promising strategies for improving the efficiency and safety of chemotherapeutic drugs. The success trisulfide bonds (-SSS-) in DPNAs makes polysulfide a worthwhile focus. Here, we explore comprehensive role tetrasulfide (-SSSS-) constructing superior DPNAs. Compared to disulfide bonds, endow with superlative self-assembly stability, prolonged blood circulation, high tumor accumulation. Notably, ultra-high reduction responsivity make highly selective "tumor bomb" that can be ignited by endogenous reducing agents cells. Furthermore, present an "add fuel flames" strategy intensify reductive stress at sites replenishing exogenous agents, making considerable progress inhibition. This work elucidates crucial establishing intelligent DPNAs, alongside combination methodology, propelling new heights potent cancer therapy.

Язык: Английский

Процитировано

16

Activated aggregation‐induced emission therapeutics agents for triggering regulated cell death DOI Creative Commons

Yu‐Qiang Zhao,

Le Yu,

Lanyun Zhang

и другие.

Aggregate, Год журнала: 2024, Номер 5(3)

Опубликована: Янв. 22, 2024

Abstract The induction of regulated cell death (RCD) through photo/ultrasound sensitization therapeutic agents has gained significant attention as a vital approach to combat drug resistance in tumors. Aggregation‐induced emission (AIE) generate reactive oxygen species activation, which can synergize with RCD inducers or directly induce RCD, ultimately resulting the tumor cells. presented comprehensive review delves into recent advancements AIE designed trigger inducers, encompassing apoptosis, necroptosis, pyroptosis, immunogenic death, autophagy, ferroptosis, and cuproptosis. Additionally, intricate regulatory mechanisms activatory‐AIE therapeutics influence distinct pathways are examined. A forward‐looking perspective on future developments pertinent challenges within this exciting realm is presented, anticipating continued evolution activatable transformative enhance therapy.

Язык: Английский

Процитировано

14